Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,217,186 papers from all fields of science
Search
Sign In
Create Free Account
COL4A4 gene
Known as:
COLLAGEN OF BASEMENT MEMBRANE, ALPHA-4 CHAIN
, CA44
, COLLAGEN, TYPE IV, ALPHA-4
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
COL4A1 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.
D. Cosgrove
,
Shiguang Liu
Matrix Biology
2017
Corpus ID: 31194878
Highly Cited
2013
Highly Cited
2013
COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.
H. Storey
,
J. Savige
,
V. Sivakumar
,
S. Abbs
,
F. Flinter
Journal of the American Society of Nephrology
2013
Corpus ID: 6450211
Alport syndrome is an inherited disease characterized by hematuria, progressive renal failure, hearing loss, and ocular…
Expand
Highly Cited
2009
Highly Cited
2009
Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and…
A. Pierides
,
K. Voskarides
,
+11 authors
C. Deltas
Nephrology, Dialysis and Transplantation
2009
Corpus ID: 41505162
BACKGROUND Heterozygous mutations in the COL4A3/ COL4A4 genes are currently thought to be responsible for familial benign…
Expand
Highly Cited
2009
Highly Cited
2009
Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus
M. Štabuc-Šilih
,
M. Ravnik-Glavač
,
D. Glavač
,
M. Hawlina
,
Mojca Strazisar
Molecular Vision
2009
Corpus ID: 6736266
Purpose Alterations in collagen type IV, alpha-3 (COL4A3) and collagen type IV, alpha-4 (COL4A4) genes may be responsible for a…
Expand
Highly Cited
2007
Highly Cited
2007
The podocyte-specific inactivation of Lmx1b, Ldb1 and E2a yields new insight into a transcriptional network in podocytes.
H. Suleiman
,
D. Heudobler
,
+11 authors
R. Witzgall
Developmental Biology
2007
Corpus ID: 12971193
Highly Cited
2004
Highly Cited
2004
Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
C. Pescucci
,
F. Mari
,
+9 authors
A. Renieri
Kidney International
2004
Corpus ID: 8377630
BACKGROUND Alport syndrome is a clinically and genetically heterogeneous nephropathy. The majority of cases are transmitted as an…
Expand
Highly Cited
2003
Highly Cited
2003
Mutations in the COL4A4 gene in thin basement membrane disease.
M. Buzza
,
H. Dagher
,
+4 authors
J. Savige
Kidney International
2003
Corpus ID: 23123275
BACKGROUND Patients with thin basement membrane disease (TBMD) are often from families where hematuria segregates with the COL4A3…
Expand
Highly Cited
2001
Highly Cited
2001
COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
M. Buzza
,
Yan Yan Wang
,
+5 authors
J. Savige
Kidney International
2001
Corpus ID: 43564503
BACKGROUND Carriers of autosomal-recessive and X-linked Alport syndrome often have a thinned glomerular basement membrane (GBM…
Expand
Highly Cited
1999
Highly Cited
1999
Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome.
Wei Lu
,
Carrie Phillips
,
+6 authors
M. Meisler
Genomics
1999
Corpus ID: 39929741
Mice homozygous for the transgenic insertion in line OVE250 exhibit severe progressive glomerulonephritis. Ultrastructural…
Expand
1997
1997
IgE from latex-allergic patients binds to cloned and expressed B cell epitopes of prohevein.
B. Banerjee
,
X. Wang
,
K. Kelly
,
J. Fink
,
G. Sussman
,
V. Kurup
Journal of Immunology
1997
Corpus ID: 7317024
Prohevein is one of the major allergens associated with latex allergy. In the present study, we identified IgE binding regions of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE